Evidence map›Paper›PMID 38632496›Full record

ReviewNature reviews. Genetics2024

Natural antisense transcripts as versatile regulators of gene expression.

Andreas Werner, Aditi Kanhere, Claes Wahlestedt, John S Mattick

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. The Versatile Applications of Antisense Oligonucleotides in Modern Medicine.International journal of molecular sciences · 2026
    Review
  8. Family-Based Study RevealsInternational journal of molecular sciences · 2026
    Article
  9. TheBiology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Direct roles of long non-coding RNAs in transcription activation.Nature structural & molecular biology · 2026
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Andreas WernerNewcastle University, Newcastle, UK. andreas.werner@ncl.ac.uk.ORCID 0000-0002-2274-0662
Aditi KanhereUniversity of Liverpool, Liverpool, UK.ORCID 0000-0001-5464-9006
Claes WahlestedtUniversity of Miami Miller School of Medicine, Miami, FL, USA.ORCID 0000-0003-4471-5916
John S MattickUniversity of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0002-7680-7527
Newcastle College · GBUniversity of Liverpool · GBUniversity of Miami · USUNSW Sydney · AU

Funding

NIH HHS AA29924NIH HHS AG079373
6 · The paper itself

Abstract

Long non-coding RNAs (lncRNAs) are emerging as a major class of gene products that have central roles in cell and developmental biology. Natural antisense transcripts (NATs) are an important subset of lncRNAs that are expressed from the opposite strand of protein-coding and non-coding genes and are a genome-wide phenomenon in both eukaryotes and prokaryotes. In eukaryotes, a myriad of NATs participate in regulatory pathways that affect expression of their cognate sense genes. Recent developments in the study of NATs and lncRNAs and large-scale sequencing and bioinformatics projects suggest that whether NATs regulate expression, splicing, stability or translation of the sense transcript is influenced by the pattern and degrees of overlap between the sense-antisense pair. Moreover, epigenetic gene regulatory mechanisms prevail in somatic cells whereas mechanisms dependent on the formation of double-stranded RNA intermediates are prevalent in germ cells. The modulating effects of NATs on sense transcript expression make NATs rational targets for therapeutic interventions.

Indexed as

Gene Expression RegulationRNA, AntisenseRNA, Long NoncodingAnimalsEpigenesis, GeneticHumansRNA, AntisenseRNA, Long Noncoding

Identifiers

PMID38632496
OpenAlexW4394904455

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.